Protracted low dose of oral vinorelbine and temozolomide with whole-brain radiotherapy in the treatment for breast cancer patients with brain metastases

[1] Lin NU(2004)CNS metastases in breast cancer J Clin Oncol 22 3608-3617

[2] Bellon JR(2007)Multidisciplinary management of brain metastases Oncologist 12 884-898

[3] Winer EP(2005)Current treatment paradigms for the management of patients with brain metastases Neurosurgery 57 S66-S77

[4] Eichler AF(2010)Current treatment strategies for brain metastasis and complications from therapeutic techniques: a review of current literature Am J Clin Oncol 33 398-407

[5] Loeffler JS(2011)The oral tyrosine kinase inhibitors lapatinib and sunitinib: new opportunities for the treatment of brain metastases from breast cancer? Expert Rev Anticancer Ther 11 139-142

[6] Ewend MG(2005)Current management of brain metastases, with a focus on systemic options J Clin Oncol 23 6207-6219

[7] Elbabaa S(2003)Plasma and cerebrospinal fluid pharmacokinetics of intravenous temozolomide in non-human primates J Neurooncol 61 203-207

[8] Carey LA(2006)Temozolomide in metastatic breast cancer (MBC): a phase II trial of the national cancer institute of Canada–clinical trials group (NCIC-CTG) Ann Oncol 17 952-995

[9] Platta CS(2002)Phase II randomized trial of temozolomide and concurrent radiotherapy in patients with brain metastases J Clin Oncol 20 3644-3650

[10] Khuntia D(2007)Concomitant treatment of brain metastasis with whole brain radiotherapy [WBRT] and temozolomide [TMZ] is active and improves quality of life BMC Cancer 7 18-2531

[1] Lin NU(2004)CNS metastases in breast cancer J Clin Oncol 22 3608-3617

[2] Bellon JR(2007)Multidisciplinary management of brain metastases Oncologist 12 884-898

[3] Winer EP(2005)Current treatment paradigms for the management of patients with brain metastases Neurosurgery 57 S66-S77

[4] Eichler AF(2010)Current treatment strategies for brain metastasis and complications from therapeutic techniques: a review of current literature Am J Clin Oncol 33 398-407

[5] Loeffler JS(2011)The oral tyrosine kinase inhibitors lapatinib and sunitinib: new opportunities for the treatment of brain metastases from breast cancer? Expert Rev Anticancer Ther 11 139-142

[6] Ewend MG(2005)Current management of brain metastases, with a focus on systemic options J Clin Oncol 23 6207-6219

[7] Elbabaa S(2003)Plasma and cerebrospinal fluid pharmacokinetics of intravenous temozolomide in non-human primates J Neurooncol 61 203-207

[8] Carey LA(2006)Temozolomide in metastatic breast cancer (MBC): a phase II trial of the national cancer institute of Canada–clinical trials group (NCIC-CTG) Ann Oncol 17 952-995

[9] Platta CS(2002)Phase II randomized trial of temozolomide and concurrent radiotherapy in patients with brain metastases J Clin Oncol 20 3644-3650

[10] Khuntia D(2007)Concomitant treatment of brain metastasis with whole brain radiotherapy [WBRT] and temozolomide [TMZ] is active and improves quality of life BMC Cancer 7 18-2531